Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
     L01A ALKYLATING AGENTS
     L01B ANTIMETABOLITES
       L01BA Folic acid analogues
         L01BA01 Methotrexate [DG:DG00681]
         L01BA03 Raltitrexed
         L01BA04 Pemetrexed [DG:DG00682]
         L01BA05 Pralatrexate
           D05589  Pralatrexate (JAN/USAN/INN) <JP/US>
       L01BB Purine analogues
       L01BC Pyrimidine analogues
     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
     L01X OTHER ANTINEOPLASTIC AGENTS
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: February 22, 2019
According to WHO's ATC 2019

» Japanese version